Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions

Tsuyoshi Otsuji1 Department of Ophthalmology, Kansai Medical University, Takii Hospital, Osaka, JapanCorrespondence[email protected]

Kenichiro Sho2 Department of Ophthalmology, Kansai Medical University, Hirakata Hospital, Osaka, Japan

Akiko Tsumura1 Department of Ophthalmology, Kansai Medical University, Takii Hospital, Osaka, Japan

Naoko Koike1 Department of Ophthalmology, Kansai Medical University, Takii Hospital, Osaka, Japan

Tetsuya Nishimura1 Department of Ophthalmology, Kansai Medical University, Takii Hospital, Osaka, Japan

Kanji Takahashi2 Department of Ophthalmology, Kansai Medical University, Hirakata Hospital, Osaka, Japan

Pages 431-436 | Published online: 11 Mar 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

OtsujiTNagaiYShoKInitial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)Clin Ophthalmol201371487149023901256
PubMedGoogle Scholar
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) study groupPhotodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials – TAP reportArch Ophthalmol1999117101329134510532441
PubMed Web of Science ®Google Scholar
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) study groupPhotodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2Arch Ophthalmol2001119219820711176980
PubMedGoogle Scholar
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) study groupVerteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition’s impact on vision outcomes – TAP report No 3Arch Ophthalmol2002120111443145412427056
PubMedGoogle Scholar
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) study groupVerteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials – TAP report No.5Arch Ophthalmol2002120101307131412365909
PubMedGoogle Scholar
TanoYOphthalmic PDT Study GroupGuidelines for PDT in JapanOphthalmology20081153585585.e618319105
PubMed Web of Science ®Google Scholar
KohALeeWKChenLJEVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathyRetina20123281453146422426346
PubMed Web of Science ®Google Scholar
Schmidt-ErfurthUMichelsSBarbazettoILaquaHPhotodynamic effects on choroidal neovascularization and physiological choroidInvest Ophthalmol Vis Sci200243383084111867605
PubMed Web of Science ®Google Scholar
Schmidt-ErfurthULaquaHSchlötzer-SchrehardUViestenzANaumannGOHistopathological changes following photodynamic therapy in human eyesArch Ophthalmol2002120683584412049594
PubMedGoogle Scholar
MichelsSHansmannFGeitzenauerWSchmidt-ErfurthUInfluence of treatment parameters on selectivity of verteporfin therapyInvest Ophthalmol Vis Sci200647137137616384987
PubMed Web of Science ®Google Scholar
YamashitaAShiragaFShiragamiCShirakataYFujiwaraATwo-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathyAm J Ophthalmol2013155196102.e122995028
PubMed Web of Science ®Google Scholar
SakuraiMBabaTKitahashiMOne-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathyClin Ophthalmol2014823524124511222
PubMedGoogle Scholar
RosenblattBJShahGKBlinderKPhotodynamic therapy with verteporfin for peripapillary choroidal neovascularizationRetina2005251333715655438
PubMed Web of Science ®Google Scholar
WachtlinJSpyridakiMStrouxABechrakisNEFoersterMTherapy for peripapillary located and large choroidal haemangioma with PDT ‘paint-brush technique’Klin Monbl Augenheilkd200922611933938 German19798625
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date